This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Sep;27(9):1658-9.

doi: 10.1093/annonc/mdw268. Epub 2016 Jul 19.

PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?

Affiliations

PMID: 27436847
DOI: 10.1093/annonc/mdw268

Free article

Editorial

PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?

H Al-Ahmadie. Ann Oncol. 2016 Sep.

Free article

. 2016 Sep;27(9):1658-9.

doi: 10.1093/annonc/mdw268. Epub 2016 Jul 19.

Author

Affiliation

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, USA.

PMID: 27436847
DOI: 10.1093/annonc/mdw268

No abstract available

PubMed Disclaimer

Comment on

Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.
Udager AM, Liu TY, Skala SL, Magers MJ, McDaniel AS, Spratt DE, Feng FY, Siddiqui J, Cao X, Fields KL, Morgan TM, Palapattu GS, Weizer AZ, Chinnaiyan AM, Alva A, Montgomery JS, Tomlins SA, Jiang H, Mehra R. Udager AM, et al. Ann Oncol. 2016 Sep;27(9):1706-12. doi: 10.1093/annonc/mdw216. Epub 2016 May 23. Ann Oncol. 2016. PMID: 27217541 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program